Blood Preparation Market Report 2026
Global Outlook – By Product (Whole Blood, Blood Components, Blood Derivatives), By Antithrombotic And Anticoagulants Type (Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants), By Application (Transfusion, Diagnostics, Research), By End User (Hospitals, Clinics, Blood Banks, Other End-Users) - Market Size, Trends, Strategies, and Forecast to 2030
Blood Preparation Market Overview
• Blood Preparation market size has reached to $51.13 billion in 2025 • Expected to grow to $71.08 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: Blood Donation Driving Growth In The Blood Preparation Market • Market Trend: Innovations in Blood Preparation By Advancing Blood Transfusion Accuracy Through Multiplex Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Blood Preparation Market?
Blood preparation refers to the process of collecting, processing, and storing blood and blood components for use in transfusions or other medical treatments. The blood preparation process involves donor screening, blood collection, testing, storage, and transfusion. The main types of blood preparation products are whole blood, blood components, and blood derivatives. Whole blood refers to a type of blood that has not been separated into its individual components, such as red blood cells, white blood cells, and plasma. It includes different types of antithrombotic and anticoagulants, such as platelet aggregation inhibitors, fibrinolytics, and anticoagulants, which are applied in transfusion, diagnostics, and research. The primary end-users include hospitals, clinics, blood banks, and others.
What Is The Blood Preparation Market Size and Share 2026?
The blood preparation market size has grown strongly in recent years. It will grow from $51.13 billion in 2025 to $54.47 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increasing blood donation programs, expansion of hospital transfusion services, rising trauma and surgical cases, improvements in blood testing protocols, growth of centralized blood banks.What Is The Blood Preparation Market Growth Forecast?
The blood preparation market size is expected to see strong growth in the next few years. It will grow to $71.08 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing demand for safe blood supply, rising investments in blood processing automation, expansion of component separation technologies, growing emphasis on transfusion safety, integration of digital blood management systems. Major trends in the forecast period include increasing automation of blood collection and processing, rising demand for component-based transfusions, expansion of advanced blood storage systems, growing focus on donor screening and traceability, enhanced cold chain management.
Global Blood Preparation Market Segmentation
1) By Product: Whole Blood, Blood Components, Blood Derivatives 2) By Antithrombotic And Anticoagulants Type: Platelet Aggregation Inhibitors, Fibrinolytics, Anticoagulants 3) By Application: Transfusion, Diagnostics, Research 4) By End User: Hospitals, Clinics, Blood Banks, Other End-Users Subsegments: 1) By Whole Blood: Fresh Whole Blood, Stored Whole Blood 2) By Blood Components: Red Blood Cells (RBC), Platelets, Plasma, White Blood Cells (WBC) 3) By Blood Derivatives: Immunoglobulins, Coagulation Factors, Albumin, FibrinogenWhat Is The Driver Of The Blood Preparation Market?
The increasing number of blood donations worldwide is expected to boost the growth of the blood preparation market going forward. Blood donation refers to the process of donating blood to save the lives of others. It makes blood transfusion possible as a life-sustaining and life-saving treatment. Patients require blood to survive surgeries, cancer treatment, chronic illnesses, and traumatic traumas. It enables transfusion during the blood preparation process, ensuring that blood is always available whenever and wherever it is required. For instance, in June 2024, according to China's National Health Commission, a China-based government agency overseeing public health policy and healthcare administration, in 2023, voluntary blood donations in China reached a record 16.99 million, representing a 5.9% increase over 2022 and highlighting continued strengthening of the national blood supply system. Therefore, rising in blood donation is driving the growth of the blood preparation industry.Key Players In The Global Blood Preparation Market
Major companies operating in the blood preparation market are AstraZeneca PLC, Sanofi, LEO Pharma A/S, Bristol-Myers Squibb Company, Baxter International Inc, Pfizer Inc, Portola Pharmaceuticals Inc, GlaxoSmithKline PLC, Bayer AG, Boehringer Ingelheim, Celgene Corp, Shandong East Chemical Industry Co., Xiamen Hisunny Chemical Co. LTD, Merck & Co., Amgen Inc., Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., AbbVie Inc., Roche Holding AG, CSL Behring, BioMarin Pharmaceutical Inc., Genentech Inc., Sandoz International GmbH, Medtronic plc, Fresenius Kabi AG, Grifols S.A., HemaCare Corporation, Terumo Corporation
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Blood Preparation Market Trends and Insights
Major companies operating in the blood preparation market are focusing on product innovation, such as multiplex testing, which allows for simultaneous analysis of multiple blood group antigens and antibody screenings in a single well. Multiplex testing is a laboratory technique that allows multiple tests to be performed simultaneously on a single sample and can detect or measure many targets in parallel, saving time and sample volume. For instance, in June 2024, Innobiochips SAS, a France-based biotechnology company, introduced Omnys, an advanced blood grouping and testing solution designed to enhance the accuracy and efficiency of blood transfusion procedures, reflecting ongoing trends of automation and precision in blood preparation. Additionally, it also offers multiplex testing platforms and integrated software solutions.What Are Latest Mergers And Acquisitions In The Blood Preparation Market?
In March 2023, Werfen, a Spain-based specialized diagnostics and medical equipment manufacturing company, acquired Immucor, Inc. for an undisclosed amount. Through this acquisition, Werfen aims to expand its diagnostics portfolio by integrating Immucor’s transfusion and transplant product lines, strengthening its position in the blood-preparation and transfusion diagnostics market while broadening its global reach in specialized diagnostics. Immucor, Inc. is a U.S.-based transfusion and transplant diagnostics company known for its in vitro diagnostics solutions that facilitate patient-donor compatibility in blood transfusion and transplantation.
Regional Outlook
North America was the largest region in the blood preparation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global blood preparation market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Blood Preparation Market?
The blood preparation market consists of revenues earned by entities by providing services such as blood processing, blood storing, and distributing blood and blood components for transfusion services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood preparation market also includes sales of red cells, platelets, cryoprecipitated AHF (CRYO), and granulocytes, which are used in providing blood preparation services. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Blood Preparation Market Report 2026?
The blood preparation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the blood preparation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Blood Preparation Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $54.47 billion |
| Revenue Forecast In 2030 | $71.08 billion |
| Growth Rate | CAGR of 6.9% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product, Antithrombotic And Anticoagulants Type, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain |
| Key Companies Profiled | AstraZeneca PLC, Sanofi, LEO Pharma A/S, Bristol-Myers Squibb Company, Baxter International Inc, Pfizer Inc, Portola Pharmaceuticals Inc, GlaxoSmithKline PLC, Bayer AG, Boehringer Ingelheim, Celgene Corp, Shandong East Chemical Industry Co., Xiamen Hisunny Chemical Co. LTD, Merck & Co., Amgen Inc., Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., AbbVie Inc., Roche Holding AG, CSL Behring, BioMarin Pharmaceutical Inc., Genentech Inc., Sandoz International GmbH, Medtronic plc, Fresenius Kabi AG, Grifols S.A., HemaCare Corporation, Terumo Corporation |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |